Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
44.47
0.00
(0.00%)
At close: October 30 at 8:10:35 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 5 | 6 | 7 |
| Avg. Estimate | 30.77M | 34.43M | 126.8M | 158.86M |
| Low Estimate | 25.5M | 28.1M | 121.5M | 140.54M |
| High Estimate | 38.99M | 45.59M | 135.01M | 182.71M |
| Year Ago Sales | 42.71M | 37.57M | 140.6M | 126.8M |
| Sales Growth (year/est) | -27.96% | -8.35% | -9.82% | 25.29% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLNK.MX | -- | -- | -- | -- |
| S&P 500 | 15.57% | 7.51% | 10.59% | 14.14% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 2/4/2025 |
| Maintains | UBS: Neutral to Neutral | 1/27/2025 |
| Reiterates | Needham: Buy to Buy | 1/15/2025 |
| Downgrade | UBS: Buy to Neutral | 11/14/2024 |
| Reiterates | Benchmark: Buy to Buy | 11/12/2024 |
| Maintains | UBS: Buy to Buy | 10/15/2024 |